Clinical Trial: Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232758) titled 'Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration' on Nov. 14.

Brief Summary: This study mainly evaluated the safety and tolerability, as well as the pharmacokinetic characteristics, of the injectable drug HRS-2183 after single and multiple administrations in healthy subjects.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Chinese Healthy Adult Subjects

Intervention: DRUG: HRS-2183

HRS-2183

DRUG: Placebo

placebo

Recruitment Status: RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Disclaimer: Curated by HT ...